Physician profile
Daniel J Fuchs
NPI 1265727283
$6,497.65
in general payments reported to CMS, 2019-2025
14 companies · $4,589 in 2025
The $4,589 reported for 2025 was more than what 81% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $165 · 2021: $32.59 · 2022: $1,332 · 2023: $181 · 2024: $198 · 2025: $4,589.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,955 · Food and Beverage: $1,013.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,955.00 |
| Food and Beverage | $1,012.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $3,955.00 | 2025 | Na |
| Paladin Technology Solutions | $1,200.00 | 2022 | |
| Smith+Nephew, INC. | $381.33 | 2021-2025 | Panta 2, Cadence |
| Depuy Synthes Sales INC. | $206.05 | 2019-2025 | Va-Lcp |
| Kuros Biosciences USA, INC | $161.41 | 2025 | Magnetos |
| Stryker Corporation | $159.09 | 2025 | Insignia, Pangea |
| Paragon 28, INC. | $114.97 | 2025 | Trauma |
| Arthrex, INC. | $113.66 | 2023 | Distal Extremities Implants Trauma Ankle Fracture |
| Treace Medical Concepts, INC. | $93.22 | 2022-2025 | |
| Bioventus LLC | $39.55 | 2025 | Exogen Ultrasound Bone Healing System |
| Highridge Medical LLC | $25.64 | 2024 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Medtronic, INC. | $22.81 | 2025 | Intellis Adaptivestim |
| Acumed LLC | $13.26 | 2019 | |
| Boston Scientific Corporation | $11.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Fuchs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.